Vertigo associated with diseases affecting the vestibular system

Active Ingredient: Meclozine

Indication for Meclozine

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

Meclizine is indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.

For this indication, competent medicine agencies globally authorize below treatments:

25-100 mg daily, in divided doses

For:

Dosage regimens

Oral, between 25 milligrams meclozine and 100 milligrams meclozine, divided daily.

Detailed description

The recommended dosage is 25 mg to 100 mg daily administered orally, in divided doses, depending upon clinical response.

Active ingredient

Meclozine

Meclizine is a first generation antihistamine that is used largely to treat vertigo and motion sickness.

Read more about Meclozine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.